Clariant AG/€CLN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Clariant AG
Clariant AG is a global specialty chemicals company headquartered in Muttenz, Switzerland. The company operates through several segments including Care Chemicals, Catalysis, and Natural Resources. Care Chemicals focus on consumer goods, industrial applications, as well as agriculture, offering products such as surfactants and polymers. Catalysis provides solutions for the petrochemical and refining industries, while Natural Resources cover oil and mining services. Founded in 1995 as a spin-off from Sandoz, Clariant has expanded its geographic footprint across Europe, North America, Latin America, and Asia. Its strategic strength lies in developing innovative and sustainable solutions aimed at enhancing customer performance, with a strong focus on R&D and bespoke product offerings.
- Ticker
- €CLN
- Sector
- Materials
- Primary listing
- XGAT
- Employees
- 10,107
- Headquarters
- Muttenz, Switzerland
- Website
- www.clariant.com
Clariant AG Metrics
BasicAdvanced
€3.8B
-
-€0.11
0.45
€0.46
3.93%
Price and volume
Market cap
€3.8B
Beta
0.45
52-week high
€11.90
52-week low
€7.18
Average daily volume
708K
Dividend rate
€0.46
Financial strength
Current ratio
1.77
Quick ratio
0.954
Long term debt to equity
0.826
Total debt to equity
0.977
Interest coverage (TTM)
6.02%
Profitability
EBITDA (TTM)
617.639
Gross margin (TTM)
30.98%
Net profit margin (TTM)
-0.82%
Operating margin (TTM)
9.58%
Effective tax rate (TTM)
100.22%
Revenue per employee (TTM)
€415,470
Management effectiveness
Return on assets (TTM)
3.83%
Return on equity (TTM)
-0.01%
Valuation
Price to revenue (TTM)
0.925
Price to book
1.75
Price to tangible book (TTM)
6.4
Price to free cash flow (TTM)
10.261
Free cash flow yield (TTM)
9.75%
Free cash flow per share (TTM)
1.136
Dividend yield (TTM)
3.93%
Growth
Revenue change (TTM)
-6.62%
Earnings per share change (TTM)
-129.44%
3-year revenue growth (CAGR)
-8.30%
10-year revenue growth (CAGR)
-4.21%
3-year earnings per share growth (CAGR)
-24.31%
10-year earnings per share growth (CAGR)
-17.25%
10-year dividend per share growth (CAGR)
0.49%
Bulls say / Bears say
Third-quarter sales rose 5.6% in local currencies, with positive pricing and volumes in Care Chemicals and Adsorbents & Additives. This shows resilience outside the conflict-hit Catalysts business. (Clariant)
Clariant had delivered CHF 79 million of annualised savings by the end of Q3 and remains on track for CHF 90 million by year-end. If achieved, these savings should help offset cost inflation and support profitability. (Reuters)
The company says its Catalysts order book is strong for Q4 and expects sales there to match last year's level, with a better mix. That offers a near-term route to recovery if delayed customer orders resume. (Reuters)
Third-quarter adjusted EBITDA fell 6.5% and missed analysts' expectations, while the margin dropped to 15.6% from 17.9% a year earlier. Sales growth has therefore not yet translated into stronger underlying earnings. (Reuters)
The Middle East conflict is still delaying high-margin Catalysts orders and weighing on oil-services demand. Clariant's full-year sales guidance remains around flat, leaving little room for prolonged disruption. (Clariant)
Legal risk remains despite a favourable ruling in one ethylene case: Shell and Repsol have appealed, and Deutsche Bank raised its estimate of potential litigation costs to CHF 175 million. A costly outcome in the remaining claims could weigh on earnings and the share price. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
Upcoming events
No upcoming events
Funds containing Clariant AG
AllUSDEURGBP
Fund name | Fund size | €CLN weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.17% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.17% |
Xtrackers MSCI World Small Cap$XSWC | $183M | 0.01% |
Vanguard FTSE Global All-cap$VALU | $199M | 0.00% |
Vanguard FTSE Global All-cap€VGLA | €171M | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.